Leo Kunz

5PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2026
FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

|Apr 21, 2026
FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

|Mar 04, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

|Sep 16, 2021
Intercrypt sentinel macrophages tune antibacterial NF-κB responses in gut epithelial cells via TNF.

Annika Hausmann, Boas Felmy, Leo Kunz

|Jan 11, 2018
Multicolor quantitative confocal imaging cytometry.

Daniel L Coutu, Konstantinos D Kokkaliaris, Leo Kunz

Pageof 1

Frequent Collaborators

2 joint publications

Timm Schroeder

2 joint publications

Christine Trumpfheller

2 joint publications

Pablo Umaña

1 joint publications

Daniel L Coutu